Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Orthopedic Imaging Equipment Market Outlook (2021 to 2031)

[174 Pages Report] The global Orthopedic Imaging Equipment Market was valued at US$ 9.8 Billion in 2021 and is expected to reach US$ 14.6 Billion by 2031. The increasing number of accidents and sports injuries resulting in fractures and bone injuries is boosting the need for orthopedic diagnostic imaging.

Data Points Market Insights
Orthopedic Imaging Equipment Market Value 2020 US$ 9.3 Billion
Orthopedic Imaging Equipment Market Market Value 2031 US$ 14.6 Billion
CAGR 2021 to 2031 4.0%
Share of Top 5 Countries 58.6%
Key Players General Electric Healthcare Limited, Siemens AG, Esaote SPA, Hitachi Ltd, Koninklijke Philips N.V, PLANMED OY, EOS imaging

Imaging technologies such as magnetic resonance imaging (MRI), computed tomography (CT or CAT), and ultrasound have opened new therapy possibilities with little morbidity. The increasing prevalence of orthopedic diseases such as osteoporosis, arthritis, elbow pain, and others have increased the demand for diagnosis and diagnostic equipment across the globe.

According to the Centers for Disease Control and Prevention (CDC), in The USA, around 72 million people will be affected by arthritis by 2030. Against this backdrop, demand for orthopedic imaging equipment is expected to bolster in the USA, making it one of the most lucrative pockets in the global market.

The orthopedic imaging equipment market holds nearly 31% of the medical imaging equipment market, totaling US$ 29.5 Billion by the end of 2031. There have been significant developments in medical imaging technology and orthopedic imaging equipment devices.

Subsequently, increased rates of bone disease and accidents resulting in bone injuries are driving the need for effective orthopedic diagnostic imaging.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

How The Market Progressed Till June 2022?

Particulars Details
H1, 2021 4.84%
H1, 2022 Projected 3.94%
H1, 2022 Outlook 3.64%
BPS Change - H1, 2022 (O) - H1, 2022 (P) (-) 30 ↓
BPS Change - H1, 2022 (O) - H1, 2021 (-) 120 ↓

The global orthopaedic imaging equipment market is subject to devise regulations, product patents, licensing requirements, and quality and safety assessment, as per all the macro and industry standards.

The key developments in the market include the development of advanced 3D imaging and software modelling of the target imaging field. The market is highly influenced by the growing adoption of portable or hand-held imaging devices, and the utilization of predictive modelling to identify surgical interventional sites for enhanced patient compliance with treatment.

The H1-2022 outlook period in comparison to H1-2022 projected period showed negative growth in terms of Basis Point Share by 30 BPS. And in H1-2022, the market growth rate of orthopaedic imaging equipment is expected to fall by 120 basis point shares (BPS), as per FMI analysis

The market decline observed through the reduction in the BPS values is addressed by the risk of radiation exposure during imaging, lack of qualified professional workforce to operate advanced imaging modalities, and high initial equipment cost followed by subsequently high maintenance costs.

Orthopedic Imaging Equipment Market Analysis 2016 to 2020 Vs Demand Outlook for 2021 to 2031

According to Future Market Insights, sales of orthopedic imaging equipment grew at a CAGR of 4.0% between 2016 and 2020. With the rising incidence of orthopedic diseases and bone injuries coupled with a growing geriatric population, sales are expected to reach US$ 14.6 Billion by the end of 2031.

According to a UN report, the geriatric population will increase from 9.3 % in 2020 to around 16% in 2050. This increase in population will result in more acute and chronic injuries. Hence, demand for orthopedic imaging equipment is expected to increase, boosting the market.

Additionally, the global prevalence of osteoarthritis (OA) is rapidly increasing. Also, there has been a noticeable increase in the obesity ratio across the globe. Being overweight increases the pressure exerted on joints such as the knee, causing tension and speeding up cartilage breakdown.

Hence, the risk of bone and chronic injuries is expected to accelerate over the coming years. This is expected to create growth opportunities for the orthopedic imaging equipment market players.

Orthopaedic Imaging Equipment Market

Consequently, there is also a significant shift in doctors’ preference towards innovative and advanced technologies such as advanced MRI and CT imaging techniques. Development in these techniques will result in increased demand in the market.

Further, the orthopedic imaging equipment market is expected to grow with the expansion of the healthcare industry and the surging need to discover novel technologies to effectively diagnose any issue.

Rising acceptance and quick expansion of new technologies, especially in emerging economies such as India and China will boost the market throughout the forecast period. Hence, leading companies are concentrating on introducing new products as well as research and development.

Considering this, FMI expects the global orthopedic imaging equipment market to expand at over a CAGR of 5.4%, in terms of volume, through 2021.

High Cost and Lack of Healthcare Infrastructure to Limit Sales in Underdeveloped Economies

Currently, several developing and underdeveloped nations are lacking adequate imaging infrastructure to conduct tests and technology implementation. Developed nations such as the USA have better diagnostic imaging and use advanced imaging techniques.

However, with few reimbursement policies and a lack of healthcare infrastructure, the market in underdeveloped economies in Latin America is expected to witness headwinds in the upcoming years.

These economies lack widespread access to diagnostic imaging, limiting the sales in the orthopedic imaging equipment market.

Besides this, the high cost involved in the initial setup and installation of imaging equipment and broadband technology in remote locations might hamper the growth of the global orthopedic imaging equipment market.

Additionally, the chances of recovering the costs solely depend on the number of scans arriving per day. Hence, achieving break-even is quite uncertain and entails high risk. This is expected to be the major restraining factor in the orthopedic imaging equipment market.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

Why is the USA Considered the Largest Market for Orthopedic Imaging Equipment?

In 2021, the USA is expected to account for about 89.2% of the North American orthopedic imaging equipment market. Growing incidence of arthritis, acute injuries, increasing geriatric population, and high per capita healthcare spending in the USA are some of the factors boosting the market.

Furthermore, government funding for the procurement of imaging equipment by various institutions in the USA will aid the expansion of the market.

Will the UK Emerge as the Most Lucrative Pocket in Europe Orthopedic Imaging Equipment?

As per FMI, the UK is expected to account for 13.1% of the Europe market by 2021. Growth in the country is attributable to the technological advancements in medical devices used in orthopedic imaging and favorable government policies.

As per the National Health Service (UK), more than ten million individuals suffer from arthritis or other joint-related diseases. The rising prevalence of such bone diseases will improve the demand for orthopedic imaging equipment and treatment, accelerating sales in the UK.

What are the Factors Fueling the Demand in China's Orthopedic Imaging Equipment Market?

China is projected to witness growth at a 6.9% CAGR in East Asia throughout the forecast period, opines Future Market Insights.

The increasing geriatric population and growing prevalence of osteoarthritis and other bone diseases are propelling the growth of China's orthopedic imaging equipment market.

According to the World Health Organization (WHO), by 2040, the geriatric population is expected to grow by 28% in China.

How will the Orthopedic Imaging Equipment Market Expand Across India?

Demand for orthopedic imaging equipment in India is expected to rise at an impressive 6.3% CAGR over the forecast period, finds Future Market Insights.

Increasing research and development activities, rapid growth in medical device technology, and increasing adoption of medical devices are aiding the growth of the orthopedic imaging equipment market in India.

Category-wise Insights

Why are X-Ray Systems Most Preferred as Orthopedic Imaging Equipment?

By product, the X-ray system segment is anticipated to hold the maximum share of 28.0 % in 2021. The segment is expected to exhibit growth at 3.3% CAGR during the forecast period.

The demand for X-rays is expected to outpace the sales of other imaging equipment, owing to several advantages of X-rays such as easy availability, accessibility, and cost-effectiveness.

They are more accessible than MRI and can be used to identify injuries and masses within the body more quickly. X-rays are one of the most cost-effective and widely used imaging techniques across developing economies such as India and China.

Will the Increase Prevalence of Acute Injuries Propel Orthopedic Imaging Equipment Sales?

In terms of indication, the acute injuries segment is projected to dominate the market. As per FMI, the segment is expected to account for 56.6% of the total market share in 2021.

Growth in the segment is underpinned by an increase in accidental cases, sports injuries, and bone dislocation across the globe. According to the research study on acute injuries, over 30 million children participate in organized sports activities, among them nearly 3.5 million undergo severe acute injuries.

More than 775,000 children are treated in hospital emergency rooms for such injuries, resulting in the need for advanced orthopedic imaging equipment.

Will Need for Orthopedic Imaging Equipment in Hospitals Outpace in Radiology Centers?

In terms of end-user, hospitals, and radiology centers, collectively, hold over 60% of the market share in 2021 and this trend is expected to continue during the forecast period as well.

A growing number of standalone imaging centers is propelling the growth in the radiology centers segment. Also, independent imaging centers provide discounts in order to attract more people, aiding the growth of the segment.

In addition, the time it takes for patients to have an MRI or other imaging procedure in radiology centers is reduced. Hence, the adoption of orthopedic imaging equipment will increase in radiology centers. 

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape

Companies in the orthopedic imaging equipment market are pursuing new product innovations and launches, regulatory approvals, and expansion of their product portfolios as key strategies.

Key players are also focusing on the development of advanced and cost-effective products establishing distribution agreements to expand their global footprints, especially in Asia Pacific.

Moreover, companies are targeting Indian and China markets by establishing manufacturing units in order to reduce manufacturing costs. For instance:

  • Canon Inc. purchased Toshiba Corp.'s medical division in December 2016. Canon Inc. has joined the diagnostic imaging devices market as a result of the purchase, using Toshiba Medicals' diagnostic imaging expertise. Canon's biomedical industry would be strengthened much more as a result of this purchase.
  • On September 2016, FDA approved the OnSight 3D Extremity System by Carestream Health. This system offers high-quality point-of-care imaging for sports and orthopedic practices.
  • Siemens Healthineers opened its next-generation manufacturing plant in Bengaluru in September 2019, with a total investment of INR 200 million, to create diagnostic imaging and advanced therapies products.

Scope of the Report

Attribute Details
Forecast Period 2021 to 2031
Historical Data Available for 2016 to 2020
Market Analysis USD Million for Value
Key Regions Covered North America, Latin America, Europe, South Asia and Pacific, East Asia, and Middle East & Africa (MEA)
Key Countries Covered The USA, Canada, Brazil, Mexico, Argentina, Germany, The UK, France, Italy, Spain, Benelux, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Thailand, Indonesia, Australia, and New Zealand, Egypt, Turkey, South Africa, North Africa, and GCC Countries
Key Segments Covered Product, Indication, End User, and Region
Key Companies Profiled
  • General Electric Healthcare Limited
  • Siemens AG
  • Esaote SPA
  • Hitachi Ltd
  • Koninklijke Philips N.V
  • Planmed OY
  • EOS imaging
  • Canon Medical Systems Corporation
  • Neusoft Corporation
  • Carestream Health
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Customization & Pricing Available upon Request

Orthopedic Imaging Equipment Market by Category

By Product:

  • X-Ray Systems
  •  CT-Scanner
  • MRI Systems
  • EOS Imaging Systems
  • Ultrasound
  • Nuclear Imaging Systems

By Indication:

  •  Acute injuries
    • Sports injuries
    • Trauma cases
  • Chronic Disorders
    • Osteoarthritis
    • Osteoporosis
    • Prolapsed Disc
    • Degenerative joint diseases
  • Others

By End-User:

  • Hospitals
  • Radiology Centers
  • Emergency Care Facility
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How big is the orthopedic imaging equipment market?

The global orthopedic imaging equipment market is worth US$ 9.8 Billion in 2021 and is set to expand by 1.5X over the next ten years.

What is the sales forecast for orthopedic imaging equipment market through 2031?

The orthopedic imaging equipment market is expected to reach US$ 14.6 Billion, with sales increasing at a 4.0% CAGR by the end of 2031.

What are the factors driving the demand outlook of the global orthopedic imaging equipment?

Sales in the orthopedic imaging equipment market are expected to increase owing to the rising government and private body initiatives and surging demand for 3D medical imaging equipment.

Which is the most lucrative market for orthopedic imaging equipment?

North America currently holds the largest market share in the orthopedic imaging equipment market globally. The region is expected to contribute over 30.5% of the sales in the orthopedic imaging equipment market. As per FMI, the USA is expected to spearhead the growth, surpassing US$ 2.5 Billion in 2021.

At rate will the Japan orthopedic imaging equipment market grow?

Japan’s market for orthopedic imaging equipment is expected to exhibit healthy growth at 4.3% CAGR during the forecast period.

What are the top 5 countries driving demand for orthopedic imaging equipment?

The USA, Russia, Poland, China, and Japan are the top 5 countries driving the demand in the orthopedic imaging equipment market.

Table of Content

1. Executive Summary | Orthopaedic Imaging Equipment Market

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Technological Roadmap

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Innovation / Key Development Trends

    3.3. New Launches / Approvals

4. Market Background

    4.1. Macro-Economic Factors

        4.1.1. Global GDP Growth Outlook

        4.1.2. Global Healthcare Expenditure Outlook

        4.1.3. Emerging Countries Healthcare and Development Outlook

    4.2. Forecast Factors - Relevance & Impact

        4.2.1. Adoption of Device Product

        4.2.2. Prevalence of Orthopaedic Disorders

        4.2.3. Historical growth of key players

        4.2.4. New product launches and approvals

        4.2.5. COVID-19 Impact

        4.2.6. Reimbursement scenario

        4.2.7. Expansion by Leading Manufacturer in Emerging Geographies

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunity Analysis

5. Market Context

    5.1. List of Manufacturers and Suppliers

    5.2. Usage/ Adoption Analysis

    5.3. Promotional Strategies by Key Manufacturer

    5.4. Technological Advancements

    5.5. Regulatory Scenario

    5.6. Porter’s Analysis

    5.7. PESTLE Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as Compared to 2008 financial analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. Revenue By Product

        6.4.2. Revenue By Indication

        6.4.3. Revenue By End User

        6.4.4. Revenue By Region

    6.5. 2021 Market Scenario

7. Global Market Volume (Units) Analysis 2016 to 2020 and Forecast, 2021 to 2031

    7.1. Historical Market Volume (Units) Analysis, 2016 to 2020

    7.2. Current and Future Market Volume (Units) Projections, 2021 to 2031

        7.2.1. Y-o-Y Growth Trend Analysis

8. Market -Pricing Analysis

    8.1. Regional Pricing Analysis By Indication

    8.2. Pricing Break-up

        8.2.1. Manufacturer-Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Average Pricing Analysis Benchmark

9. Global Market Value (US$ Million) Analysis 2016 to 2020 and Forecast, 2021 to 2031

    9.1. Historical Market Value (US$ Million) Analysis, 2016 to 2020

    9.2. Current and Future Market Value (US$ Million) Projections, 2021 to 2031

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Product, 2016 to 2020

    10.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2021 to 2031

        10.3.1. X-Ray Systems

        10.3.2. CT-Scanner

        10.3.3. Orthopaedic Imaging Equipment

        10.3.4. EOS Imaging Systems

        10.3.5. Ultrasound

        10.3.6. Nuclear Imaging Systems

    10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Million) Analysis, By Indication, 2016 to 2020

    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2021 to 2031

        11.3.1. Acute injuries

            11.3.1.1. Sports injuries

            11.3.1.2. Trauma cases

        11.3.2. Chronic Disorders

            11.3.2.1. Osteoarthritis

            11.3.2.2. Osteoporosis

            11.3.2.3. Prolapsed Disc

            11.3.2.4. Degenerative joint diseases

        11.3.3. Market Attractiveness Analysis By Indication

12. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Million) Analysis By End User, 2016 to 2020

    12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2021 to 2031

        12.3.1. Hospitals

        12.3.2. Radiology Centers

        12.3.3. Emergency Care Facility

        12.3.4. Ambulatory Surgical Centres

    12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2016 to 2020 and Forecast 2021 to 2031, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2016 to 2020

    13.3. Current Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2021 to 2031

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. South Asia

        13.3.5. East Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2016 to 2020 and Forecast 2021 to 2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020

    14.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031

        14.3.1. By Country

            14.3.1.1. The USA

            14.3.1.2. Canada

        14.3.2. By Product

        14.3.3. By Indication

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Latin America Market Analysis 2016 to 2020 and Forecast 2021 to 2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020

    15.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031

        15.3.1.  By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Product

        15.3.3. By Indication

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031

    16.1. Introduction

    16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020

    16.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031

        16.3.1.  By Country

            16.3.1.1. The UK

            16.3.1.2. Germany

            16.3.1.3. France

            16.3.1.4. Italy

            16.3.1.5. Spain

            16.3.1.6. Russia

            16.3.1.7. BENELUX

            16.3.1.8. Rest of Europe

        16.3.2. By Product

        16.3.3. By Indication

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis 

17. South Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031

    17.1. Introduction

    17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020

    17.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031

        17.3.1.  By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia

        17.3.2. By Product

        17.3.3. By Indication

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. East Asia Market Analysis 2016 to 2020 and Forecast 2021 to 2031

    18.1. Introduction

    18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020

    18.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031

        18.3.1.  By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

            18.3.1.4. Rest of East Asia

        18.3.2. By Product

        18.3.3. By Indication

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis 

19. Oceania Market Analysis 2016 to 2020 and Forecast 2021 to 2031

    19.1. Introduction

    19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020

    19.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031

        19.3.1.  By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Product

        19.3.3. By Indication

        19.3.4. By End User

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Market Analysis 2016 to 2020 and Forecast 2021 to 2031

    20.1. Introduction

    20.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2016 to 2020

    20.3. Market Size (US$ Million) and Volume (Units) Forecast By Market Taxonomy, 2021 to 2031

        20.3.1.  By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Turkey

            20.3.1.3. Northern Africa

            20.3.1.4. South Africa

            20.3.1.5. Rest of Middle East and Africa

        20.3.2. By Product

        20.3.3. By Indication

        20.3.4. By End User

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Countries Level Market Analysis 2021 & 2031

    21.1. Introduction

        21.1.1. Market Value Proportion Analysis, By Key Countries

        21.1.2. Global Vs. Country Growth Comparison

        21.1.3. Pricing Analysis

    21.2. The USA Market Analysis

        21.2.1. By Product

        21.2.2. By Indication

        21.2.3. By End User

    21.3. Canada Market Analysis

        21.3.1. By Product

        21.3.2. By Indication

        21.3.3. By End User

    21.4. Mexico Market Analysis

        21.4.1. By Product

        21.4.2. By Indication

        21.4.3. By End User

    21.5. Brazil Market Analysis

        21.5.1. By Product

        21.5.2. By Indication

        21.5.3. By End User

    21.6. The UK Market Analysis

        21.6.1. By Product

        21.6.2. By Indication

        21.6.3. By End User

    21.7. Germany Market Analysis

        21.7.1. By Product

        21.7.2. By Indication

        21.7.3. By End User

    21.8. France Market Analysis

        21.8.1. By Product

        21.8.2. By Indication

        21.8.3. By End User

    21.9. Italy Market Analysis

        21.9.1. By Product

        21.9.2. By Indication

        21.9.3. By End User

    21.10. Spain Market Analysis

        21.10.1. By Product

        21.10.2. By Indication

        21.10.3. By End User

    21.11. BENELUX Market Analysis

        21.11.1. By Product

        21.11.2. By Indication

        21.11.3. By End User

    21.12. Russia Market Analysis

        21.12.1. By Product

        21.12.2. By Indication

        21.12.3. By End User

    21.13. China Market Analysis

        21.13.1. By Product

        21.13.2. By Indication

        21.13.3. By End User

    21.14. Japan Market Analysis

        21.14.1. By Product

        21.14.2. By Indication

        21.14.3. By End User

    21.15. South Korea Market Analysis

        21.15.1. By Product

        21.15.2. By Indication

        21.15.3. By End User

    21.16. India Market Analysis

        21.16.1. By Product

        21.16.2. By Indication

        21.16.3. By End User

    21.17. Indonesia Market Analysis

        21.17.1. By Product

        21.17.2. By Indication

        21.17.3. By End User

    21.18. Thailand Market Analysis

        21.18.1. By Product

        21.18.2. By Indication

        21.18.3. By End User

    21.19. Malaysia Market Analysis

        21.19.1. By Product

        21.19.2. By Indication

        21.19.3. By End User

    21.20. Australia Market Analysis

        21.20.1. By Product

        21.20.2. By Indication

        21.20.3. By End User

    21.21. New Zealand Market Analysis

        21.21.1. By Product

        21.21.2. By Indication

        21.21.3. By End User

    21.22. GCC Countries Market Analysis

        21.22.1. By Product

        21.22.2. By Indication

        21.22.3. By End User

    21.23. Turkey Market Analysis

        21.23.1. By Product

        21.23.2. By Indication

        21.23.3. By End User

    21.24. South Africa Market Analysis

        21.24.1. By Product

        21.24.2. By Indication

        21.24.3. By End User

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies

    22.2. Market Share Analysis of Top Players

    22.3. Market Concentration

    22.4. Market Presence Analysis

        22.4.1. By Regional Footprint of Players

        22.4.2. Product foot print by Players

        22.4.3. Channel foot print by Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive 

        23.3.1. GE Healthcare

            23.3.1.1. Overview

            23.3.1.2. Product Portfolio

            23.3.1.3. Analyst Commentary

            23.3.1.4. Key Financials

            23.3.1.5. Recent Developments

            23.3.1.6. Profitability by Market Segments (Product / Channel / Region)

            23.3.1.7. Sales Footprint

            23.3.1.8. Strategy Overview

                23.3.1.8.1. Marketing Strategy

                23.3.1.8.2. Product Strategy

                23.3.1.8.3. Channel Strategy

        23.3.2. Koninklijke Philips N.V.

            23.3.2.1. Overview

            23.3.2.2. Product Portfolio

            23.3.2.3. Analyst Commentary

            23.3.2.4. Key Financials

            23.3.2.5. Recent Developments

            23.3.2.6. Profitability by Market Segments (Product / Channel / Region)

            23.3.2.7. Sales Footprint

            23.3.2.8. Strategy Overview

                23.3.2.8.1. Marketing Strategy

                23.3.2.8.2. Product Strategy

                23.3.2.8.3. Channel Strategy

        23.3.3. Siemens Healthineers

            23.3.3.1. Overview

            23.3.3.2. Product Portfolio

            23.3.3.3. Analyst Commentary

            23.3.3.4. Key Financials

            23.3.3.5. Recent Developments

            23.3.3.6. Profitability by Market Segments (Product / Channel / Region)

            23.3.3.7. Sales Footprint

            23.3.3.8. Strategy Overview

                23.3.3.8.1. Marketing Strategy

                23.3.3.8.2. Product Strategy

                23.3.3.8.3. Channel Strategy

        23.3.4. Esaote SPA

            23.3.4.1. Overview

            23.3.4.2. Product Portfolio

            23.3.4.3. Analyst Commentary

            23.3.4.4. Key Financials

            23.3.4.5. Recent Developments

            23.3.4.6. Profitability by Market Segments (Product / Channel / Region)

            23.3.4.7. Sales Footprint

            23.3.4.8. Strategy Overview

                23.3.4.8.1. Marketing Strategy

                23.3.4.8.2. Product Strategy

                23.3.4.8.3. Channel Strategy

        23.3.5. Canon Medical Systems, Inc.,

            23.3.5.1. Overview

            23.3.5.2. Product Portfolio

            23.3.5.3. Analyst Commentary

            23.3.5.4. Key Financials

            23.3.5.5. Recent Developments

            23.3.5.6. Profitability by Market Segments (Product / Channel / Region)

            23.3.5.7. Sales Footprint

            23.3.5.8. Strategy Overview

                23.3.5.8.1. Marketing Strategy

                23.3.5.8.2. Product Strategy

                23.3.5.8.3. Channel Strategy

        23.3.6. Hitachi Medical Systems

            23.3.6.1. Overview

            23.3.6.2. Product Portfolio

            23.3.6.3. Analyst Commentary

            23.3.6.4. Key Financials

            23.3.6.5. Recent Developments

            23.3.6.6. Profitability by Market Segments (Product / Channel / Region)

            23.3.6.7. Sales Footprint

            23.3.6.8. Strategy Overview

                23.3.6.8.1. Marketing Strategy

                23.3.6.8.2. Product Strategy

                23.3.6.8.3. Channel Strategy

        23.3.7. PLANMED OY

            23.3.7.1. Overview

            23.3.7.2. Product Portfolio

            23.3.7.3. Analyst Commentary

            23.3.7.4. Key Financials

            23.3.7.5. Recent Developments

            23.3.7.6. Profitability by Market Segments (Product / Channel / Region)

            23.3.7.7. Sales Footprint

            23.3.7.8. Strategy Overview

                23.3.7.8.1. Marketing Strategy

                23.3.7.8.2. Product Strategy

                23.3.7.8.3. Channel Strategy

        23.3.8. EOS imaging

            23.3.8.1. Overview

            23.3.8.2. Product Portfolio

            23.3.8.3. Analyst Commentary

            23.3.8.4. Key Financials

            23.3.8.5. Recent Developments

            23.3.8.6. Profitability by Market Segments (Product / Channel / Region)

            23.3.8.7. Sales Footprint

            23.3.8.8. Strategy Overview

                23.3.8.8.1. Marketing Strategy

                23.3.8.8.2. Product Strategy

                23.3.8.8.3. Channel Strategy

        23.3.9. Neusoft Corporation

            23.3.9.1. Overview

            23.3.9.2. Product Portfolio

            23.3.9.3. Analyst Commentary

            23.3.9.4. Key Financials

            23.3.9.5. Recent Developments

            23.3.9.6. Profitability by Market Segments (Product / Channel / Region)

            23.3.9.7. Sales Footprint

            23.3.9.8. Strategy Overview

                23.3.9.8.1. Marketing Strategy

                23.3.9.8.2. Product Strategy

                23.3.9.8.3. Channel Strategy

        23.3.10. Carestream Health

            23.3.10.1. Overview

            23.3.10.2. Product Portfolio

            23.3.10.3. Analyst Commentary

            23.3.10.4. Key Financials

            23.3.10.5. Recent Developments

            23.3.10.6. Profitability by Market Segments (Product / Channel / Region)

            23.3.10.7. Sales Footprint

            23.3.10.8. Strategy Overview

                23.3.10.8.1. Marketing Strategy

                23.3.10.8.2. Product Strategy

                23.3.10.8.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Recommendations

Healthcare

Orthopedic Trauma Device Market

Published : January 2024

Healthcare

Digital Mobile X-Ray Devices Market

Published : September 2023

Healthcare

3D Printed Medical Devices Market

Published : January 2023

Healthcare

Ultrasound Systems Market

Published : June 2022

Explore Healthcare Insights

View Reports

Orthopaedic Imaging Equipment Market